Starbucks is set to stop covering GLP-1 medications prescribed for weight loss under its employee health plans, adding to signs that employers are reassessing one of the fastest-growing areas of prescription drug spending, according to SHRM. Beginning in October, benefits-eligible Starbucks employees will no longer have coverage for GLP-1 drugs when prescribed specifically for weight loss, according to reports. Coverage can remain available whe…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.